Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

37.85
Delayed Data
As of May 05
 -0.10 / -0.26%
Today’s Change
27.68
Today|||52-Week Range
40.96
-5.40%
Year-to-Date

Today’s Trading

Previous close37.95
Today’s open38.00
Day’s range37.35 - 38.17
Volume359,900
Average volume (3 months)425,286
Market cap$1.5B
Dividend yield--
Data as of 4:02pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)+27.19%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+16.14%
P/E ratio28.4
Price/Sales3.62
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.07-0.68%
TXMDTherapeuticsMD Inc0.000.00%
HCMHutchison China Medi...-0.58-4.43%
TSROTESARO Inc-2.68-6.69%
Data as of 4:00pm ET, 05/05/2016

Financials

Last reporting dateMay 6, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers

Search for Jobs